학술논문

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
Document Type
Article
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, August 2023, 23(8):956-964)
Subject
Language
English
ISSN
14744457
14733099